Literature DB >> 27235175

Expression, purification, and buffer solubility optimization of the putative human peptidyl-tRNA hydrolase PTRHD1.

Geordan L Burks1, Hana McFeeters1, Robert L McFeeters2.   

Abstract

Performing the essential function of recycling peptidyl-tRNAs, peptidyl-tRNA hydrolases are ubiquitous in all domains of life. The multicomponent eukaryotic Pth system differs greatly from the bacterial system composed predominantly of a single Pth1 enzyme. While bacterial Pth1s are structurally well characterized and promising new targets for antibiotic development, eukaryotic Pths are largely understudied. From amino acid sequence alignment and secondary structure predictions, the human gene product PTRHD1 was classified as a eukaryotic Pth. Herein, we report cloning, recombinant bacterial expression, and weak binding to peptidyl-tRNA for PTRHD1. Additionally, we report binding to tRNA but absence of peptidyl-tRNA hydrolase activity. Thus, PTRHD1 is not a Pth and the functional consequence of nucleotide binding remains undefined.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C2orf79; PTRHD1; Peptidyl-tRNA hydrolase domain containing 1; Purification; Recombinant expression; Solubility optimization

Mesh:

Substances:

Year:  2016        PMID: 27235175     DOI: 10.1016/j.pep.2016.05.011

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Biallelic PTRHD1 Frameshift Variants Associated with Intellectual Disability, Spasticity, and Parkinsonism.

Authors:  Ghalia Al-Kasbi; Abeer Al-Saegh; Ahmed Al-Qassabi; Tariq Al-Jabry; Fahad Zadjali; Said Al-Yahyaee; Almundher Al-Maawali
Journal:  Mov Disord Clin Pract       Date:  2021-09-20

2.  Functional Impact of the G279S Substitution in the Adenosine A1-Receptor (A1R-G279S7.44), a Mutation Associated with Parkinson's Disease.

Authors:  Shahrooz Nasrollahi-Shirazi; Daniel Szöllösi; Qiong Yang; Edin Muratspahic; Ali El-Kasaby; Sonja Sucic; Thomas Stockner; Christian Nanoff; Michael Freissmuth
Journal:  Mol Pharmacol       Date:  2020-09       Impact factor: 4.436

3.  Release of Ubiquitinated and Non-ubiquitinated Nascent Chains from Stalled Mammalian Ribosomal Complexes by ANKZF1 and Ptrh1.

Authors:  Kazushige Kuroha; Alexandra Zinoviev; Christopher U T Hellen; Tatyana V Pestova
Journal:  Mol Cell       Date:  2018-09-20       Impact factor: 17.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.